Ticker Scorecard - RPRX Basics Company: Royalty Pharma plc IPO Date: June 16, 2020 Sector: Healthcare Industry: Biotech Market Cap: $14.48B Activated in VL: True Average Daily Range Avg Daily Range: $0.46 | 1.21% Avg Daily Range (30 D): $0.33 | 1.09% Avg Daily Range (90 D): $0.27 | 0.96% Institutional Daily Volume Avg Daily Volume: 1.89M Avg Daily Volume (30 D): 4.08M Avg Daily Volume (90 D): 2.81M Trade Size Avg Trade Size (Sh.): 94 Avg Trade Size (Sh.) (30 D): 123 Avg Trade Size (Sh.) (90 D): 108 Institutional Trades Total Inst.Trades: 7,154 Avg Inst. Trade: $4.29M Avg Inst. Trade (30 D): $5.61M Avg Inst. Trade (90 D): $5.21M Avg Inst. Trade Volume: .12M Avg Inst. Trades (Per Day): 6 Market Closing Trades Avg Closing Trade: $11.85M Avg Closing Trade (30 D): $15.82M Avg Closing Trade (90 D): $13.27M Avg Closing Volume: 333.17K     News Feb 12, 2025 @ 2:39 PM Biogen Q4 Earnings: Revenue And EPS Beat, Warns Lo... Source: Vandana Singh Jan 10, 2025 @ 12:15 PM Royalty Pharma Announces Transformative Step in Co... Source: Globe Newswire Dec 13, 2024 @ 9:30 AM 3 High-Yield Dividend Stocks to Buy in 2025 and Ho... Source: Cory Renauer Dec 4, 2024 @ 10:37 AM 2 Exceptional Dividend Stocks Near 52-Week Lows Yo... Source: The Motley Fool Nov 14, 2024 @ 10:20 AM 3 High-Yield Dividend Stocks You Can Buy With $130... Source: Cory Renauer Financials   TTM Q3 2024 Q2 2024 Basic EPS $2.56 $1.22 $.23 Diluted EPS $2.54 $1.21 $.23 Revenue $ 2.27B $ 564.69M $ 537.27M Gross Profit $ $ $ Net Income / Loss $ 1.71B $ 806.36M $ 194.38M Operating Income / Loss $ 1.54B $ 735.07M $ 269.63M Cost of Revenue $ $ $ Net Cash Flow $ 13.6M $ -814.59M $ 921.64M PE Ratio 13.16     Splits Oct 15, 2010:   4:1